S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets – Trademark Portfolio
Entity Type: 03
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ASSERACHROM. The owner is based in Asnieres.
6 ter, rue Denis Papis
Asnieres , FR
Showing of trademarks Trademarks
Trademark Classifications
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets have?
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 5 cancelled.
What trademark classes does S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets file in?
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets's most well-known trademarks?
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets's registered trademark portfolio includes well-known marks such as ASSERACHROM. These are among 1 currently registered trademark in the portfolio.
What is S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets's trademark registration success rate?
S.E.M.S. Societe d'Etudes et d'Exploitation de Marques et Brevets has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.